CDT Equity CDT
NASDAQ CDT
$0.40 -0.04 (-9.09%)
At close: Nov 13, 2026 · 4:00 PM EST

CDT Equity (CDT) Sale and Maturity of Investments (2023 - 2024)

Updated

Analysis

CDT Equity (CDT) Sale and Maturity of Investments (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 308.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - 88.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 2.53 Bn
10 CDT Equity 426.40 -6.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 85,000.00
Sep 30, 2024 137,000.00
Jun 30, 2023 828,780.00
Mar 31, 2023 114.03 Mn
API Access

CDT Equity Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=CDT&period=max&api_key=YOUR_API_KEY